Radioconjugates targeting cd33 in the treatment of breast cancer
US-2026053963-A1 · Feb 26, 2026 · US
Actinium Pharmaceuticals Inc holds 79 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 79 |
| Recent patents | 40 |
| First publication | Jan 3, 2017 |
| Latest publication | Feb 26, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026053963-A1 · Feb 26, 2026 · US
US-12551584-B1 · Feb 17, 2026 · US
US-12539340-B2 · Feb 3, 2026 · US
US-2026000795-A1 · Jan 1, 2026 · US
US-12491274-B2 · Dec 9, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026053963-A1 · Feb 26, 2026 · US
US-12551584-B1 · Feb 17, 2026 · US
US-12539340-B2 · Feb 3, 2026 · US
US-2026000795-A1 · Jan 1, 2026 · US
US-12491274-B2 · Dec 9, 2025 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61K51/1096 | 58 |
| A61K51/1027 | 49 |
| A61P35/00 | 45 |
| C07K16/2803 | 38 |
| A61K51/1093 | 36 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 78 |
| Chemistry & Metallurgy | 74 |
| Physics | 9 |
| Operations & Transport | 4 |
| Cross-Sectional Technologies | 4 |
| Electricity | 1 |
Answers are generated from the same data shown on this page.